These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 7787154)
1. Ras oncogene and p53 gene hotspot mutations in colorectal cancers. Lin SY; Chen PH; Yang MJ; Chen TC; Chang CP; Chang JG J Gastroenterol Hepatol; 1995; 10(2):119-24. PubMed ID: 7787154 [TBL] [Abstract][Full Text] [Related]
2. Analysis of K-ras codon 12 mutations and p53 overexpression in colorectal nodule-aggregating tumors. Kusaka T; Fukui H; Sano Y; Ueda Y; Chiba T; Fujimori T J Gastroenterol Hepatol; 2000 Oct; 15(10):1151-7. PubMed ID: 11106095 [TBL] [Abstract][Full Text] [Related]
3. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance. Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410 [TBL] [Abstract][Full Text] [Related]
4. Alterations of the p53 tumor suppressor gene and its association with activation of the c-K-ras-2 protooncogene in premalignant and malignant lesions of the human uterine endometrium. Enomoto T; Fujita M; Inoue M; Rice JM; Nakajima R; Tanizawa O; Nomura T Cancer Res; 1993 Apr; 53(8):1883-8. PubMed ID: 8385572 [TBL] [Abstract][Full Text] [Related]
5. Mutations of the p53 tumor suppressor gene and the ras gene family in intrahepatic cholangiocellular carcinomas in Japan and Thailand. Kiba T; Tsuda H; Pairojkul C; Inoue S; Sugimura T; Hirohashi S Mol Carcinog; 1993; 8(4):312-8. PubMed ID: 8280380 [TBL] [Abstract][Full Text] [Related]
6. p53 and K-ras gene mutations correlate with tumor aggressiveness but are not of routine prognostic value in colorectal cancer. Tortola S; Marcuello E; González I; Reyes G; Arribas R; Aiza G; Sancho FJ; Peinado MA; Capella G J Clin Oncol; 1999 May; 17(5):1375-81. PubMed ID: 10334521 [TBL] [Abstract][Full Text] [Related]
7. K-ras and p53 mutations in DNA extracted from colonic epithelial cells exfoliated in faeces of patients with colorectal cancer. Notarnicola M; Cavallini A; Cardone R; Pezzolla F; Demma I; Di Leo A Dig Liver Dis; 2000 Mar; 32(2):131-6. PubMed ID: 10975788 [TBL] [Abstract][Full Text] [Related]
8. [A study on the mutation of P53 and K-ras gene in colorectal adenomas and colorectal carcinomas]. Xu W; Cheng Y; Shen XF Sichuan Da Xue Xue Bao Yi Xue Ban; 2012 Nov; 43(6):821-6. PubMed ID: 23387205 [TBL] [Abstract][Full Text] [Related]
9. Clonal analysis of colorectal tumors using K-ras and p53 gene mutations as markers. Dix BR; Robbins PD; Spagnolo DV; Padovan GL; House AK; Iacopetta BJ Diagn Mol Pathol; 1995 Dec; 4(4):261-5. PubMed ID: 8634782 [TBL] [Abstract][Full Text] [Related]
10. Genetic events in sporadic colorectal adenomas: K-ras and p53 heterozygous mutations are not sufficient for malignant progression. De Benedetti L; Varesco L; Pellegata NS; Losi L; Gismondi V; Casarino L; Sciallero S; Bonelli L; Biticchi R; Bafico A Anticancer Res; 1993; 13(3):667-70. PubMed ID: 8317895 [TBL] [Abstract][Full Text] [Related]
11. Using biopsy materials to detect mutations in gastrointestinal tumors. Hosoi H; Hirosawa S; Yamamoto K; Ohkusa T; Aoki N J Clin Gastroenterol; 1995 Jun; 20(4):272-6. PubMed ID: 7665812 [TBL] [Abstract][Full Text] [Related]
12. Clinical significance of p53, K-ras and DCC gene alterations in the stage I-II colorectal cancers. Akkiprik M; Ataizi-Celikel C; Düşünceli F; Sönmez O; Gulluoglu BM; Sav A; Ozer A J Gastrointestin Liver Dis; 2007 Mar; 16(1):11-7. PubMed ID: 17410283 [TBL] [Abstract][Full Text] [Related]
13. K-ras mutation and loss of heterozygosity of the adenomatous polyposis coli gene in patients with colorectal adenomas with in situ carcinoma. Zauber NP; Sabbath-Solitare M; Marotta SP; Bishop DT Cancer; 1999 Jul; 86(1):31-6. PubMed ID: 10391560 [TBL] [Abstract][Full Text] [Related]
14. Mutation analysis of p53, K-ras, and BRAF genes in colorectal cancer progression. Calistri D; Rengucci C; Seymour I; Lattuneddu A; Polifemo AM; Monti F; Saragoni L; Amadori D J Cell Physiol; 2005 Aug; 204(2):484-8. PubMed ID: 15702478 [TBL] [Abstract][Full Text] [Related]
15. Concurrent mutation in exons 1 and 2 of the K-ras oncogene in colorectal cancer. Palmirotta R; Savonarola A; Ludovici G; De Marchis ML; Covello R; Ettorre GM; Ialongo C; Guadagni F Folia Histochem Cytobiol; 2011; 49(4):729-33. PubMed ID: 22252770 [TBL] [Abstract][Full Text] [Related]
16. Occurrence of point mutations in p53 gene is not increased in patients with acute myeloid leukaemia carrying an activating N-ras mutation. Bühler-Leclerc M; Gratwohl A; Senn HP Br J Haematol; 1993 Jul; 84(3):443-50. PubMed ID: 8217795 [TBL] [Abstract][Full Text] [Related]
17. Ki-ras codon 12 point mutational activation in Hong Kong colorectal carcinoma patients. Ko JM; Cheung MH; Wong CM; Lau KW; Tang CM; Kwan MW; Lung ML Cancer Lett; 1998 Dec; 134(2):169-76. PubMed ID: 10025877 [TBL] [Abstract][Full Text] [Related]
18. APC and p53 mutations in de novo colorectal adenocarcinomas. Aoki T; Takeda S; Yanagisawa A; Kato Y; Ajioka Y; Watanabe H; Kudo S; Nakamura Y Hum Mutat; 1994; 3(4):342-6. PubMed ID: 8081386 [TBL] [Abstract][Full Text] [Related]
19. Concurrent mutations of K-ras oncogene at codons 12 and 22 in colon cancer. Miyakura Y; Sugano K; Fukayama N; Konishi F; Nagai H Jpn J Clin Oncol; 2002 Jun; 32(6):219-21. PubMed ID: 12110640 [TBL] [Abstract][Full Text] [Related]
20. A double germline mutations in the APC and p53 genes. Zajac V; Tomka M; Ilenciková D; Májek P; Stevurková V; Kirchhoff T Neoplasma; 2000; 47(6):335-41. PubMed ID: 11263856 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]